ZA943015B - 8-substituted xanthines as selective adenosine receptor agents - Google Patents

8-substituted xanthines as selective adenosine receptor agents

Info

Publication number
ZA943015B
ZA943015B ZA943015A ZA943015A ZA943015B ZA 943015 B ZA943015 B ZA 943015B ZA 943015 A ZA943015 A ZA 943015A ZA 943015 A ZA943015 A ZA 943015A ZA 943015 B ZA943015 B ZA 943015B
Authority
ZA
South Africa
Prior art keywords
adenosine receptor
selective adenosine
receptor agents
substituted xanthines
xanthines
Prior art date
Application number
ZA943015A
Other languages
English (en)
Inventor
Norton P Peet
Nelsen L Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA943015B publication Critical patent/ZA943015B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA943015A 1993-05-06 1994-05-02 8-substituted xanthines as selective adenosine receptor agents ZA943015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5852393A 1993-05-06 1993-05-06

Publications (1)

Publication Number Publication Date
ZA943015B true ZA943015B (en) 1995-01-30

Family

ID=22017346

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943015A ZA943015B (en) 1993-05-06 1994-05-02 8-substituted xanthines as selective adenosine receptor agents

Country Status (14)

Country Link
US (1) US5734052A (fi)
EP (1) EP0697020A1 (fi)
JP (1) JPH08509977A (fi)
CN (1) CN1043473C (fi)
AU (1) AU676323B2 (fi)
CA (1) CA2159989C (fi)
FI (1) FI955257A (fi)
HU (1) HUT72327A (fi)
IL (1) IL109521A (fi)
MX (1) MX9403382A (fi)
NO (1) NO954399L (fi)
NZ (1) NZ265790A (fi)
WO (1) WO1994026744A1 (fi)
ZA (1) ZA943015B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025362A (en) * 1998-08-31 2000-02-15 Fukunaga; Atsuo F. Uses of xanthine compounds
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
US8871751B2 (en) * 2008-01-18 2014-10-28 The Board Of Trustees Of The University Of Illinois Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5087827A (en) * 1991-02-11 1992-02-11 Tektronix, Inc. Variable voltage transition circuit
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents

Also Published As

Publication number Publication date
US5734052A (en) 1998-03-31
AU676323B2 (en) 1997-03-06
EP0697020A1 (en) 1996-02-21
IL109521A (en) 1999-09-22
JPH08509977A (ja) 1996-10-22
CN1043473C (zh) 1999-05-26
NO954399D0 (no) 1995-11-03
AU6703294A (en) 1994-12-12
CN1122599A (zh) 1996-05-15
FI955257A0 (fi) 1995-11-02
HUT72327A (en) 1996-04-29
MX9403382A (es) 1995-01-31
WO1994026744A1 (en) 1994-11-24
IL109521A0 (en) 1994-08-26
NO954399L (no) 1996-01-08
NZ265790A (en) 1996-10-28
CA2159989A1 (en) 1994-11-24
CA2159989C (en) 1994-11-24
FI955257A (fi) 1995-11-02
HU9503154D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
AU6781194A (en) 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
AP8800099A0 (en) Therapeuric acyclic nucleosides
IL88999A0 (en) Dideoxydidehydrocarbocyclic nucleosides
GB9218810D0 (en) Antiviral pyrimidine nucleosides
PL309610A1 (en) Purine derivatives
ZA912038B (en) Selective adenosine receptor agents
EP1019404A4 (en) PURIN ACYCLONUCELOTIDES AS AN ANTIVIRAL AGENT
OA09697A (en) Nucleoside derivatives
HU9503154D0 (en) 8-substituted xanthines as selective adenosine receptor agents
ZA902282B (en) Selective adenosine receptor compounds
HU9603105D0 (en) Adenosine derivatives
EP0450102A4 (en) Nucleoside derivative
GB9514268D0 (en) Pyrimidine nucleoside
GB9606264D0 (en) Pyrimidine nucleoside derivatives
GB9318282D0 (en) Further antiviral pyrimidine nucleosides
GB9316933D0 (en) Antiviral pyrimidine nucleosides
GB9222203D0 (en) Nucleoside analogues
GB9409904D0 (en) Imidazopyrimidine nucleoside analogues
GB8922322D0 (en) Antiviral nucleosides
GB9508479D0 (en) Imidazopyrimidine nucleoside analogues
GB9514267D0 (en) Pyrimidine nucleosides
GB8925039D0 (en) Nucleoside derivatives
GB8925037D0 (en) Nucleoside derivatives
GB9218812D0 (en) Further antiviral pyrimidine nucleosides